Hematologist
ErasmusMC
Rotterdam, Zuid-Holland, Netherlands
Annemiek Broijl has been a staff member of the Department of Hematology at the Erasmus MC Cancer Institute in Rotterdam, The Netherlands since 2013. She is trained as a hematologist in the Department of Hematology at the Erasmus MC Cancer Institute, and obtained her PhD cum laude in 2012 with her thesis entitled ‘Molecular Profiling in Multiple Myeloma’ under the supervision of Professor Pieter Sonneveld. Dr Broijl’s current activities are focused on organizing clinical trials in multiple myeloma with a strong correlative program. Her interest is mainly in the molecular characterization of the disease and the patient, as well as the bone marrow micro-environment and adaptive immune system in the patient in order to identify disease and patient related factors involved in resistance/sensitivity to therapy. She combines active patient care with translational studies in the hematology laboratory. She plays an active role in the national myeloma working group (MWG), is member of the international Myeloma Working Group (IMWG), and member and chairperson of the Young European Myeloma Network (EMN) board
Wednesday, September 27, 2023
5:45 PM – 6:45 PM EEST